Antibacterial activity of extracellular compounds produced by a Pseudomonas strain against methicillin-resistant Staphylococcus aureus (MRSA) strains
Open Access
- 1 January 2013
- journal article
- research article
- Published by Springer Science and Business Media LLC in Annals of Clinical Microbiology and Antimicrobials
- Vol. 12 (1), 12-8
- https://doi.org/10.1186/1476-0711-12-12
Abstract
Background The emergence of multidrug-resistant bacteria is a world health problem. Staphylococcus aureus, including methicillin-resistant S. aureus (MRSA) strains, is one of the most important human pathogens associated with hospital and community-acquired infections. The aim of this work was to evaluate the antibacterial activity of a Pseudomonas aeruginosa-derived compound against MRSA strains. Methods Thirty clinical MRSA strains were isolated, and three standard MRSA strains were evaluated. The extracellular compounds were purified by vacuum liquid chromatography. Evaluation of antibacterial activity was performed by agar diffusion technique, determination of the minimal inhibitory concentration, curve of growth and viability and scanning electron microscopy. Interaction of an extracellular compound with silver nanoparticle was studied to evaluate antibacterial effect. Results The F3 (ethyl acetate) and F3d (dichloromethane- ethyl acetate) fractions demonstrated antibacterial activity against the MRSA strains. Phenazine-1-carboxamide was identified and purified from the F3d fraction and demonstrated slight antibacterial activity against MRSA, and synergic effect when combined with silver nanoparticles produced by Fusarium oxysporum. Organohalogen compound was purified from this fraction showing high antibacterial effect. Using scanning electron microscopy, we show that the F3d fraction caused morphological changes to the cell wall of the MRSA strains. Conclusions These results suggest that P. aeruginosa-produced compounds such as phenazines have inhibitory effects against MRSA and may be a good alternative treatment to control infections caused by MRSA.This publication has 39 references indexed in Scilit:
- Isolation of antibacterial compounds from Quercus dilatata L. through bioassay guided fractionationAnnals of Clinical Microbiology and Antimicrobials, 2012
- Antibacterial activity against β- lactamase producing Methicillin and Ampicillin-resistants Staphylococcus aureus: fractional Inhibitory Concentration Index (FICI) determinationAnnals of Clinical Microbiology and Antimicrobials, 2012
- In Vitro Antibacterial Activity of three Indian Spices Against Methicillin-Resistant Staphylococcus aureusOman Medical Journal, 2011
- Inhibition of Growth of Highly Resistant Bacterial and Fungal Pathogens by a Natural ProductThe Open Microbiology Journal, 2011
- Synergistic antimicrobial activity between pentacyclic triterpenoids and antibiotics against Staphylococcus aureus strainsAnnals of Clinical Microbiology and Antimicrobials, 2011
- A Natural Plasmid Uniquely Encodes Two Biosynthetic Pathways Creating a Potent Anti-MRSA AntibioticPLOS ONE, 2011
- Purification, crystal structure and antimicrobial activity of phenazine-1-carboxamide produced by a growth-promoting biocontrol bacterium,Pseudomonas aeruginosaMML2212Journal of Applied Microbiology, 2010
- 6-Hydroxymethyl-1-phenazine-carboxamide and 1,6-phenazinedimethanol from a marine bacterium, Brevibacterium sp. KMD 003, associated with marine purple vase spongeThe Journal of Antibiotics, 2009
- A New Type of Tripropeptin with Anteiso-branched Chain Fatty Acid from Lysobacter sp. BMK333-48F3The Journal of Antibiotics, 2008
- Some Notes on the Astringencies of Red Rose and Pale Rose**Read before Pennsylvania State Pharmaceutical Association, 1921.The Journal of the American Pharmaceutical Association (1912), 1922